Drugs that contain Risdiplam
1. Drug name - EVRYSDI
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9586955 | GENENTECH INC | Compounds for treating spinal muscular atrophy |
Feb, 2033
(10 years from now) | |
| US9969754 | GENENTECH INC | Compounds for treating spinal muscular atrophy |
May, 2035
(12 years from now) | |
| CN104349777B | GENENTECH INC | For Compound For Treating Spinal Muscular Atrophy |
Feb, 2033
(10 years from now) | |
| CN104349777A | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
Feb, 2033
(10 years from now) | |
| CN106459092A | GENENTECH INC | For Compound For Treating Spinal Muscular Atrophy |
May, 2035
(12 years from now) | |
| CN106459092B | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
May, 2035
(12 years from now) | |
| IN334397B | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
May, 2035
(12 years from now) | |
| IN201647038542A | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
May, 2035
(12 years from now) | |
| EP2812004B1 | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
Feb, 2033
(10 years from now) | |
| EP2812004A2 | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
Feb, 2033
(10 years from now) | |
| EP2812004A4 | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
Feb, 2033
(10 years from now) | |
| EP3406252A1 | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
Feb, 2033
(10 years from now) | |
| EP3406252B1 | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
Feb, 2033
(10 years from now) | |
| EP3143025A1 | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
May, 2035
(12 years from now) | |
| EP3143025B1 | GENENTECH INC | Compounds For Treating Spinal Muscular Atrophy |
May, 2035
(12 years from now) | |
Treatment: NA
Dosage: FOR SOLUTION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.75MG/ML | FOR SOLUTION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.